Cargando…

Premature end of service of implantable cardioverter-defibrillator by magnetic interference with left-ventricular assist device

Detalles Bibliográficos
Autores principales:	Eiringhaus, Jörg, Zormpas, Christos, Hohmann, Stephan, Mueller-Leisse, Johanna, Hillmann, Henrike A.K., Duncker, David, Veltmann, Christian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8530919/ https://www.ncbi.nlm.nih.gov/pubmed/34712567 http://dx.doi.org/10.1016/j.hrcr.2021.07.006

Ejemplares similares

Eligibility for subcutaneous implantable cardioverter-defibrillator in patients with left ventricular assist device
por: Zormpas, Christos, et al.
Publicado: (2020)

Changes in eligibility for a subcutaneous cardioverter-defibrillator after implantation of a left ventricular assist device–A prospective analysis
por: Zormpas, Christos, et al.
Publicado: (2023)

Extended follow‐up after wearable cardioverter‐defibrillator period: the PROLONG‐II study
por: Mueller‐Leisse, Johanna, et al.
Publicado: (2021)

Feasibility and First Results of Heart Failure Monitoring Using the Wearable Cardioverter–Defibrillator in Newly Diagnosed Heart Failure with Reduced Ejection Fraction
por: Hillmann, Henrike Aenne Katrin, et al.
Publicado: (2021)

Eligibility for subcutaneous implantable cardioverter‐defibrillator in adults with congenital heart disease
por: Zormpas, Christos, et al.
Publicado: (2021)

Delayed Improvement of Left Ventricular Function in Newly Diagnosed Heart Failure Depends on Etiology—A PROLONG-II Substudy
por: Mueller-Leisse, Johanna, et al.
Publicado: (2022)

Similarly high success and low complication rates of catheter ablation for idiopathic premature ventricular contractions from the left and right ventricular outflow tract
por: Mueller-Leisse, J, et al.
Publicado: (2023)

Prediction of ablation success of idiopathic premature ventricular contractions with an inferior axis using the twelve-lead electrocardiogram
por: Mueller-Leisse, J, et al.
Publicado: (2023)

Author reply: S‐ICD eligibilities in adults with congenital heart disease
por: Zormpas, Christos, et al.
Publicado: (2021)

Depressive Symptoms and Quality of Life in Patients With Heart Failure and an Implantable Cardioverter-Defibrillator
por: Zormpas, Christos, et al.
Publicado: (2022)

Avoiding Untimely Implantable Cardioverter/Defibrillator Implantation by Intensified Heart Failure Therapy Optimization Supported by the Wearable Cardioverter/Defibrillator—The PROLONG Study
por: Duncker, David, et al.
Publicado: (2017)

Cardiac Rhythm Monitoring Using Wearables for Clinical Guidance before and after Catheter Ablation
por: Hillmann, Henrike Aenne Katrin, et al.
Publicado: (2022)

Acute echocardiographic and electrocardiographic effects of triggered left ventricular pacing
por: Pfeffer, Tobias Jonathan, et al.
Publicado: (2022)

Usage of the wearable cardioverter-defibrillator during pregnancy
por: Olic, J.-Jacqueline, et al.
Publicado: (2022)

Emerging electromagnetic interferences between implantable cardioverter-defibrillators and left ventricular assist devices
por: Yalcin, Yunus C, et al.
Publicado: (2020)

Role of the Wearable Defibrillator in Newly Diagnosed Heart Failure
por: Duncker, David, et al.
Publicado: (2018)

Defibrillators for prevention from sudden cardiac death: is it that easy?
por: Duncker, David, et al.
Publicado: (2020)

First Report of Electromagnetic Interference Between Percutaneous Ventricular Assist Device and Implantable Cardioverter-Defibrillator
por: Takahari, Kosuke, et al.
Publicado: (2023)

Electromagnetic Interference in Patients with Implanted Cardioverter-Defibrillators and Implantable Loop Recorders
por: de Sousa, Marcos, et al.
Publicado: (2002)

Influence of myopotential interference on the Wavelet discrimination algorithm in implantable cardioverter-defibrillator
por: Mizukami, Kazuya, et al.
Publicado: (2017)

A sustained ventricular tachycardia overlooked by subcutaneous implantable cardioverter-defibrillator but recognized by co-implanted transvenous implantable cardioverter defibrillator
por: Goto, Kentaro, et al.
Publicado: (2020)

Implantable cardioverter-defibrillators /
Publicado: (1994)

Oversensing of the wearable cardioverter defibrillator during bipolar ventricular stimulation
por: Manninger, Martin, et al.
Publicado: (2017)

Implantable cardioverter-defibrillator shocks and nonsustained rapid ventricular rhythms
por: Witteveen, H., et al.
Publicado: (2022)

Implantable cardioverter-defibrillator shocks and nonsustained rapid ventricular rhythms
por: Witteveen, H., et al.
Publicado: (2022)

Evolution of extravascular implantable cardioverter-defibrillator therapy for ventricular arrhythmias
por: Römers, Hans, et al.
Publicado: (2022)

Protected risk stratification with the wearable cardioverter-defibrillator: results from the WEARIT-II-EUROPE registry
por: Veltmann, Christian, et al.
Publicado: (2020)

Implantable Cardioverter-defibrillator Magnetic Interference by the iPhone 12: Is It Clinically Significant?
por: Patel, Harshil, et al.
Publicado: (2022)

Premature ventricular contractions in patients with an implantable cardioverter defibrillator cardiac resynchronization therapy device: Results from the UMBRELLA registry
por: Akerström, Finn, et al.
Publicado: (2020)

Correction to: Protected risk stratification with the wearable cardioverter-defibrillator: results from the WEARIT-II-EUROPE registry
por: Veltmann, Christian, et al.
Publicado: (2020)

Subcutaneous implantable cardioverter-defibrillator generator removal: a multicenter analysis
por: Luker, J, et al.
Publicado: (2023)

Electromagnetic Interference from Left Ventricular Assist Device (LVAD) Inhibiting the Pacing Function of an Implantable Cardioverter-Defibrillator (ICD) Device
por: Erqou, Sebhat, et al.
Publicado: (2018)

Performance of an automated external cardioverter defibrillator for inhospital ventricular malignant arrhythmia
por: Timerman, S, et al.
Publicado: (2003)

Epicardial Cardioverter Defibrillator Implantation due to Post-Fontan Ventricular Tachycardia
por: Papakonstantinou, Nikolaos A, et al.
Publicado: (2020)

Improving rates of implantable cardioverter defibrillator deactivation in end-of-life care
por: Javaid, MR, et al.
Publicado: (2018)

Implantable cardioverter defibrillators at the end of life: future perspectives on clinical practice
por: Stoevelaar, R., et al.
Publicado: (2020)

The Automatic External Cardioverter-Defibrillator
por: Martínez-Rubio, Antoni, et al.
Publicado: (2004)

Deactivation of implantable cardioverter-defibrillators
por: Wan, Darryl, et al.
Publicado: (2021)

The subcutaneous implantable cardioverter-defibrillator should be considered for all patients with an implantable cardioverter-defibrillator indication
por: Tan, Jian Liang, et al.
Publicado: (2022)

Electrical injury‐induced ventricular fibrillation documented and treated with an implantable cardioverter defibrillator
por: Higami, Shigeo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fqv8ahs5a1vvsg795sjkolc7lp